{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T19:18:20Z","timestamp":1762543100794,"version":"3.37.3"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2019,7,31]],"date-time":"2019-07-31T00:00:00Z","timestamp":1564531200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,7,31]],"date-time":"2019-07-31T00:00:00Z","timestamp":1564531200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"the National Research Foundation of Korea (NRF) funded by the Ministry of Education","award":["NRF-2017R1D1A1B03033092"],"award-info":[{"award-number":["NRF-2017R1D1A1B03033092"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Graefes Arch Clin Exp Ophthalmol"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1007\/s00417-019-04432-w","type":"journal-article","created":{"date-parts":[[2019,7,31]],"date-time":"2019-07-31T05:02:47Z","timestamp":1564549367000},"page":"2163-2172","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Short-term effects of anti-vascular endothelial growth factor on peripapillary choroid and choriocapillaris in eyes with neovascular age-related macular degeneration"],"prefix":"10.1007","volume":"257","author":[{"given":"Boram","family":"Lee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gyeongmin","family":"Yoo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheolmin","family":"Yun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1036-6562","authenticated-orcid":false,"given":"Jaeryung","family":"Oh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,7,31]]},"reference":[{"key":"4432_CR1","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1001\/archophthalmol.2011.2480","volume":"130","author":"JP Campbell","year":"2012","unstructured":"Campbell JP, Bressler SB, Bressler NM (2012) Impact of availability of anti-vascular endothelial growth factor therapy on visual impairment and blindness due to neovascular age-related macular degeneration. Arch Ophthalmol 130:794\u2013795","journal-title":"Arch Ophthalmol"},{"key":"4432_CR2","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1097\/01.iae.0000242842.14624.e7","volume":"26","author":"N Ferrara","year":"2006","unstructured":"Ferrara N, Damico L, Shams N et al (2006) Development of ranibizumab, an anti-vascular endothelial growth factor antigen binding fragment, as therapy for neovascular agerelated macular degeneration. Retina 26:859\u2013870","journal-title":"Retina"},{"key":"4432_CR3","doi-asserted-by":"publisher","first-page":"2537","DOI":"10.1016\/j.ophtha.2012.09.006","volume":"119","author":"JS Heier","year":"2012","unstructured":"Heier JS, Brown DM, Chong V et al (2012) Intravitreal aflibercept (VEGF trap-eye) in wet age-related macular degeneration. Ophthalmology 119:2537\u20132548","journal-title":"Ophthalmology"},{"key":"4432_CR4","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1136\/bjo.2009.159160","volume":"94","author":"P Mitchell","year":"2010","unstructured":"Mitchell P, Korobelnik JF, Lanzetta P et al (2010) Ranibizumab (Lucentis) in neovascular age-related macular degeneration: evidence from clinical trials. Br J Ophthalmol 94:2\u201313","journal-title":"Br J Ophthalmol"},{"key":"4432_CR5","doi-asserted-by":"publisher","first-page":"1634","DOI":"10.1136\/bjophthalmol-2015-308074","volume":"100","author":"JH Kim","year":"2016","unstructured":"Kim JH, Lee TG, Chang YS et al (2016) Short-term choroidal thickness changes in patients treated with either ranibizumab or aflibercept: a comparative study. Br J Ophthalmol 100:1634\u20131639","journal-title":"Br J Ophthalmol"},{"key":"4432_CR6","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.1007\/s00417-015-3260-3","volume":"254","author":"C Yun","year":"2016","unstructured":"Yun C, Oh J, Ahn J et al (2016) Comparison of intravitreal aflibercept and ranibizumab injections on subfoveal and peripapillary choroidal thickness in eyes with neovascular age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol 254:1693\u20131702","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"4432_CR7","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1111\/aos.12653","volume":"93","author":"JY Shin","year":"2015","unstructured":"Shin JY, Kwon KY, Byeon SH (2015) Association between choroidal thickness and the response to intravitreal ranibizumab injection in age-related macular degeneration. Acta Ophthalmol 93:524\u2013532","journal-title":"Acta Ophthalmol"},{"key":"4432_CR8","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s12886-016-0203-7","volume":"16","author":"C Yun","year":"2016","unstructured":"Yun C, Oh J, Choi KE et al (2016) Peripapillary choroidal thickness after intravitreal ranibizumab injections in eyes with neovascular age-related macular degeneration. BMC Ophthlamol 16:25","journal-title":"BMC Ophthlamol"},{"key":"4432_CR9","doi-asserted-by":"publisher","first-page":"OCT356","DOI":"10.1167\/iovs.15-18473","volume":"57","author":"ED Cole","year":"2016","unstructured":"Cole ED, Novais EA, Louzada RN et al (2016) Visualization of changes in the choriocapillaris, choroidal vessels, and retinal morphology after focal laser photocoagulation using OCT angiography. Invest Ophthalmol Vis Sci 57:OCT356\u2013OCT361","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"4432_CR10","first-page":"35","volume":"5","author":"G Lutty","year":"1999","unstructured":"Lutty G, Grunwald J, Majji AB et al (1999) Changes in choriocapillaris and retinal pigment epithelium in age-related macular degeneration. Mol Vis 5:35","journal-title":"Mol Vis"},{"key":"4432_CR11","doi-asserted-by":"publisher","first-page":"4982","DOI":"10.1167\/iovs.09-3639","volume":"50","author":"DS McLeod","year":"2009","unstructured":"McLeod DS, Grebe R, Bhutto I et al (2009) Relationship between RPE and choriocapillaris in age-related macular degeneration. Invest Ophthalmol Vis Sci 50:4982\u20134991","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"4432_CR12","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.preteyeres.2018.07.002","volume":"67","author":"E Borrelli","year":"2018","unstructured":"Borrelli E, Sarraf D, Freund KB, Sadda SR (2018) OCT angiography and evaluation of the choroid and choroidal vascular disorders. Prog Retin Eye Res 67:30\u201355","journal-title":"Prog Retin Eye Res"},{"key":"4432_CR13","first-page":"2857","volume":"35","author":"RS Ramrattan","year":"1994","unstructured":"Ramrattan RS, van der Schaft TL, Mooy CM et al (1994) Morphometric analysis of Bruch\u2019s membrane, the choriocapillaris, and the choroid in aging. Invest Ophthalmol Vis Sci 35:2857\u20132864","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"4432_CR14","doi-asserted-by":"publisher","first-page":"2364","DOI":"10.1097\/IAE.0000000000000882","volume":"35","author":"TE de Carlo","year":"2015","unstructured":"de Carlo TE, Chin AT, Bonini Filho MA et al (2015) Detection of microvascular changes in eyes of patients with diabetes but not clinical diabetic retinopathy using optical coherence tomography angiography. Retina 35:2364\u20132370","journal-title":"Retina"},{"key":"4432_CR15","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1016\/j.ajo.2007.03.007","volume":"143","author":"S Peters","year":"2007","unstructured":"Peters S, Heiduschka P, Julien S et al (2007) Ultrastructural findings in the primate eye after intravitreal injection of bevacizumab. Am J Ophthalmol 143:995\u20131002","journal-title":"Am J Ophthalmol"},{"key":"4432_CR16","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1007\/s00417-009-1054-1","volume":"247","author":"Y Shimomura","year":"2009","unstructured":"Shimomura Y, Hirata A, Ishikawa S, Okinami S (2009) Changes in choriocapillaris fenestration of rat eyes after intravitreal bevacizumab injection. Graefes Arch Clin Exp Ophthalmol 247:1089\u20131094","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"4432_CR17","doi-asserted-by":"publisher","first-page":"487","DOI":"10.3109\/02713683.2013.763990","volume":"38","author":"Y Sugimoto","year":"2013","unstructured":"Sugimoto Y, Mochizuki H, Miyagi H et al (2013) Histological findings of uveal capillaries in rabbit eyes after multiple intravitreal injections of bevacizumab. Curr Eye Res 38:487\u2013496","journal-title":"Curr Eye Res"},{"key":"4432_CR18","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1007\/s00417-015-3054-7","volume":"254","author":"C Yun","year":"2016","unstructured":"Yun C, Oh J, Ahn SE et al (2016) Peripapillary choroidal thickness in patients with early age-related macular degeneration and reticular pseudodrusen. Graefes Arch Clin Exp Ophthalmol 254:427\u2013435","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"4432_CR19","doi-asserted-by":"publisher","first-page":"1860","DOI":"10.1097\/IAE.0000000000000539","volume":"35","author":"C Yun","year":"2015","unstructured":"Yun C, Oh J, Han JY et al (2015) Peripapillary choroidal thickness in central serous chorioretinopathy: is choroid outside the macular also thick? Retina 35:1860\u20131866","journal-title":"Retina"},{"key":"4432_CR20","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1016\/S0161-6420(13)38012-9","volume":"98","author":"Early Treatment Diabetic Retinopathy Study Research Group","year":"1991","unstructured":"Early Treatment Diabetic Retinopathy Study Research Group (1991) Grading diabetic retinopathy from stereoscopic color fundus photographs\u2014an extension of the modified Airlie House classification: ETDRS report number 10. Ophthalmology 98:786\u2013806","journal-title":"Ophthalmology"},{"key":"4432_CR21","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s00417-017-3814-7","volume":"256","author":"J Ahn","year":"2017","unstructured":"Ahn J, Yoo G, Kim JT et al (2017) Choriocapillaris layer imaging with swept-source optical coherence tomography angiography in lamellar and full-thickness macular hole. Graefes Arch Clin Exp Ophthalmol 256:11\u201321","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"4432_CR22","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1016\/j.ophtha.2019.01.003","volume":"126","author":"M Zarbin","year":"2019","unstructured":"Zarbin M, Tsuboi M, Hill LF, Stoilov I (2019) Simulating an anti-vascular endothelial growth factor switch in neovascular age-related macular degeneration: a HARBOR subanalysis. Ophthalmology 126:849\u2013855","journal-title":"Ophthalmology"},{"key":"4432_CR23","doi-asserted-by":"publisher","first-page":"1857","DOI":"10.2147\/DDDT.S115121","volume":"10","author":"S Yang","year":"2016","unstructured":"Yang S, Zhao J, Sun X (2016) Resistance to anti-VEGF therapy in neovascular age-related macular degeneration: a comprehensive review. Drug Des Devel Ther 10:1857\u20131867","journal-title":"Drug Des Devel Ther"},{"key":"4432_CR24","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1089\/jop.2014.0160","volume":"31","author":"M Gharbiya","year":"2015","unstructured":"Gharbiya M, Cruciani F, Mariotti C et al (2015) Choroidal thickness changes after intravitreal antivascular endothelial growth factor therapy for age-related macular degeneration: ranibizumab versus aflibercept. J Ocul Pharmacol Ther 31:357\u2013362","journal-title":"J Ocul Pharmacol Ther"},{"key":"4432_CR25","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1080\/02713683.2017.1405045","volume":"43","author":"M Gharbiya","year":"2018","unstructured":"Gharbiya M, Giustolisi R, Marchiori J et al (2018) Comparison of short-term choroidal thickness and retinal morphological changes after intravitreal anti-VEGF therapy with ranibizumab or aflibercept in treatment-na\u00efve eyes. Curr Eye Res 43:391\u2013396","journal-title":"Curr Eye Res"},{"key":"4432_CR26","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/j.ajo.2014.12.025","volume":"159","author":"H Koizumi","year":"2015","unstructured":"Koizumi H, Kano M, Yamamoto A et al (2015) Short-term changes in choroidal thickness after aflibercept therapy for neovascular agerelated macular degeneration. Am J Ophthalmol 159:627\u2013633","journal-title":"Am J Ophthalmol"},{"key":"4432_CR27","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.1016\/j.ophtha.2012.02.022","volume":"119","author":"T Yamazaki","year":"2012","unstructured":"Yamazaki T, Koizumi H, Yamagishi T, Kinoshita S (2012) Subfoveal choroidal thickness after ranibizumab therapy for neovascular age-related macular degeneration: 12-month results. Ophthalmology 119:1621\u20131627","journal-title":"Ophthalmology"}],"container-title":["Graefe's Archive for Clinical and Experimental Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-019-04432-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00417-019-04432-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-019-04432-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,29]],"date-time":"2020-07-29T23:31:46Z","timestamp":1596065506000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00417-019-04432-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,31]]},"references-count":27,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2019,10]]}},"alternative-id":["4432"],"URL":"https:\/\/doi.org\/10.1007\/s00417-019-04432-w","relation":{},"ISSN":["0721-832X","1435-702X"],"issn-type":[{"type":"print","value":"0721-832X"},{"type":"electronic","value":"1435-702X"}],"subject":[],"published":{"date-parts":[[2019,7,31]]},"assertion":[{"value":"8 May 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 July 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 July 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Lee declares that she has no conflict of interest. Yoo declares that she has no conflict of interest. Yun declares that he has no conflict of interest. Oh received research grant from the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (NRF-2017R1D1A1B03033092).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}